Collegium Pharmaceutical Inc (COLL)

Receivables turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	459,924	438,505	430,531	422,636	400,720	314,280	280,041	251,774	255,854	301,783	299,168	291,446	281,134	286,592	361,135	441,180	518,290	515,321	504,149	494,269
Receivables	US$ in thousands	179,525	181,851	167,479	179,127	183,119	195,402	197,505	166,345	105,844	148,999	90,098	93,156	83,320	76,466	81,195	85,427	72,953	84,380	81,279	85,139
Receivables turnover		2.56	2.41	2.57	2.36	2.19	1.61	1.42	1.51	2.42	2.03	3.32	3.13	3.37	3.75	4.45	5.16	7.10	6.11	6.20	5.81

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $459,924K ÷ $179,525K
= 2.56

Collegium Pharmaceutical Inc's receivables turnover has shown a generally increasing trend over the past eight quarters, indicating improvements in the efficiency of the company in collecting payments from its customers.

The receivables turnover ratio measures how many times during a period the company collects its average accounts receivable balance. A higher turnover ratio typically indicates that the company is more successful in collecting payments from its customers in a timely manner.

In Q4 2023, Collegium Pharmaceutical Inc achieved a receivables turnover ratio of 3.16, which is an improvement compared to the previous quarter and significantly higher than the ratios reported in the same quarter of the previous years. This indicates that the company's credit policies and collection efforts have been effective in converting receivables into cash.

Overall, the increasing trend in the receivables turnover ratio reflects positively on Collegium Pharmaceutical Inc's liquidity and ability to manage its accounts receivable efficiently. However, further analysis and comparison with industry benchmarks may provide a more comprehensive understanding of the company's performance in this area.